| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/07/2009 | CN100448433C Clarithromycin enteric medicinal composition |
| 01/07/2009 | CN100448432C Method for preparing nimodipine dispersible tablet with high dissolution |
| 01/07/2009 | CN100448431C Oral disintegrated Anfenmame tablet for treating children's cold and its prepn |
| 01/07/2009 | CN100448430C Oil-in-water type nanometer grassleaved sweetflag oil emulsion oral liquid and its prepn process |
| 01/07/2009 | CN100448429C Water aqua containing clindamycin for treating acne |
| 01/06/2009 | US7473710 Bronchodilating beta-agonist compositions and methods |
| 01/06/2009 | US7473693 pyrazine carboxamide compounds of sub-micron size; improve bioavailibility/absorption, exhibit no increase in size upon storage in the aqueous medium; N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide; using a precipitation process without the need for water-immiscible solvent; obesity |
| 01/06/2009 | US7473681 Kahalalide F |
| 01/06/2009 | US7473467 Preparation of microcapsules |
| 01/06/2009 | US7473433 Pulmonary delivery of polyene antifungal agents |
| 01/06/2009 | US7473432 NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 01/06/2009 | US7473431 Injectable methadone, methadone and naltrexone, or buprenorphine and naltrexone microparticle compositions and their use in reducing consumption of abused substances |
| 01/06/2009 | US7473428 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 01/06/2009 | US7473425 Remedies for ischemic disease |
| 01/06/2009 | US7473416 Medicaments for asthma treatment |
| 01/06/2009 | US7473248 Thermally-activated reservoir devices |
| 01/06/2009 | US7473240 Valve port assembly with coincident engagement member for fluid transfer procedures |
| 01/06/2009 | US7473158 Method of lifting and supporting human breast tissue |
| 01/06/2009 | CA2474838C Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| 01/06/2009 | CA2423572C Stabilization of solid thyroid drug formulations |
| 01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
| 01/06/2009 | CA2417630C Novel compositions of minoxidil |
| 01/06/2009 | CA2414737C Pharmaceutical compositions containing tobramycin and xanthan gum |
| 01/06/2009 | CA2400818C Antibiotic and antifungal compositions |
| 01/06/2009 | CA2395331C Pharmaceutical compositions providing enhanced drug concentrations |
| 01/06/2009 | CA2387058C Injection vehicle for polymer-based formulations |
| 01/06/2009 | CA2376937C Spray drying process for preparing dry powders |
| 01/06/2009 | CA2348084C Crystallisation using supercritical or subcritical fluids |
| 01/06/2009 | CA2346133C Capsules |
| 01/06/2009 | CA2340238C Improved stability for injection solutions |
| 01/06/2009 | CA2336772C Anticariogenic dairy product and its use |
| 01/06/2009 | CA2333869C Mousse composition |
| 01/06/2009 | CA2308495C Anaesthetic formulation |
| 01/06/2009 | CA2293575C Controlled release microencapsulated ngf formulation |
| 01/06/2009 | CA2270185C Method of preparing a poorly crystalline calcium phosphate and methods of its use |
| 01/06/2009 | CA2268215C Dividable tablet and press-through pack |
| 01/06/2009 | CA2266409C Mouthwash comprising calcium and phosphate ions in supersaturated solution |
| 01/06/2009 | CA2214778C Process for the production of polymeric microparticles, microparticles that are produced according to this process as well as their use in medical diagnosis |
| 01/05/2009 | CA2636967A1 Patch and patch preparation |
| 01/05/2009 | CA2636965A1 Patch and patch preparation |
| 01/05/2009 | CA2593020A1 Medicament compounds |
| 01/02/2009 | DE102007030434A1 Flüssige Lösungsvermittler enthaltend ethoxylierte Fettalkohole und ethoxylierte Triglyceride Liquid solubilizer containing ethoxylated fatty alcohols and ethoxylated triglycerides |
| 01/01/2009 | US20090005763 Implantable Devices and Methods for Delivering Drugs and Other Substances to Treat Sinusitis and Other Disorders |
| 01/01/2009 | US20090005745 Transdermal drug delivery systems for delivering anti-inflammatory drugs |
| 01/01/2009 | US20090005432 Pharmaceutical compositions including low dosages of desmopressin |
| 01/01/2009 | US20090005408 Process for the production of an abuse-proofed dosage form |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090005317 Methods for treating a corneal disorder and promoting skin wound healing |
| 01/01/2009 | US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof |
| 01/01/2009 | US20090004722 bovine parainfluenza virus (bPIV) cDNA or RNA which may be used to express heterologous gene products; tumor antigens; cancer |
| 01/01/2009 | US20090004286 Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same |
| 01/01/2009 | US20090004285 Stable non-disintegrating dosage forms and method of making same |
| 01/01/2009 | US20090004284 Controlled release tamsulosin hydrochloride formulation |
| 01/01/2009 | US20090004283 Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-Co-Glycolide Polymers |
| 01/01/2009 | US20090004282 Method of Particle Formation |
| 01/01/2009 | US20090004281 Multiparticulate osmotic delivery system |
| 01/01/2009 | US20090004280 kit for caring for the skin intended to soften cutaneous signs of ageing |
| 01/01/2009 | US20090004279 Method For Improvement Of Tolerance For Therapeutically Effective Agents Delivered By Inhalation |
| 01/01/2009 | US20090004278 Enzymatically Crosslinked Protein Nanoparticles |
| 01/01/2009 | US20090004277 Nanoparticle dispersion containing lactam compound |
| 01/01/2009 | US20090004276 Novel injectable chitosan mixtures forming hydrogels |
| 01/01/2009 | US20090004275 Composition for Delivery of an Active Agent |
| 01/01/2009 | US20090004274 Hydrogen Bonded Hydrogels |
| 01/01/2009 | US20090004273 Polymeric device for controlled release of active agents |
| 01/01/2009 | US20090004272 Polymeric devices for controlled release of active agents |
| 01/01/2009 | US20090004271 Morselized foam for wound treatment |
| 01/01/2009 | US20090004270 Method of using guava extract |
| 01/01/2009 | US20090004268 Methods and Compositions for Treatment of an Interstitial Lung Disease |
| 01/01/2009 | US20090004267 Dosage Form with Impeded Abuse |
| 01/01/2009 | US20090004266 Nanoparticles for protein drug delivery |
| 01/01/2009 | US20090004265 Prevention and Treatment of Thromboembolic Disorders |
| 01/01/2009 | US20090004264 Methods for treating and ameliorating the symptons of inflammatory bowel diseases |
| 01/01/2009 | US20090004263 Modified release preparations containing oxcarbazepine and derivatives thereof |
| 01/01/2009 | US20090004262 Nanoparticulate formulations and methods for the making and use therof |
| 01/01/2009 | US20090004261 Pharmaceutical composition for oral administration of a pyrazole-3-carboxamide derivative |
| 01/01/2009 | US20090004260 Medicament comprising hgf gene |
| 01/01/2009 | US20090004259 Methods of preparing a therapeutic formulation comprising galectin-induced tolerogenic dendritic cells |
| 01/01/2009 | US20090004258 Drug Release from Thermosensitive Liposomes by Applying an Alternative Magnetic Field |
| 01/01/2009 | US20090004257 Transdermal administration of fentanyl and analogs thereof |
| 01/01/2009 | US20090004256 Lowly irritative adhesive patch |
| 01/01/2009 | US20090004254 Film comprising active drugs |
| 01/01/2009 | US20090004253 Composite device for the repair or regeneration of tissue |
| 01/01/2009 | US20090004252 Skin Coating Composition and Uses Thereof |
| 01/01/2009 | US20090004250 Dual release nicotine formulations, and systems and methods for their use |
| 01/01/2009 | US20090004249 Dual release nicotine formulations, and systems and methods for their use |
| 01/01/2009 | US20090004248 Dual portion dosage lozenge form |
| 01/01/2009 | US20090004246 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 01/01/2009 | US20090004245 Use of an iris simulated layer to allow aesthetic appearance drug loaded contact lens |
| 01/01/2009 | US20090004238 Implantation of encapsulated biological materials for treating diseases |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004235 Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock Animals |
| 01/01/2009 | US20090004233 Microencapsulating compositions, methods of making, methods of using and products thereof |
| 01/01/2009 | US20090004232 Bioactive pharmaceutical/cosmetic compositions and mixed solubilization process for the formulation thereof |
| 01/01/2009 | US20090004231 Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring |
| 01/01/2009 | US20090004230 Thermosetting Neutralized Chitosan Composition Forming a Hydrogel, Lyophilizate, and Processes for Producing the Same |
| 01/01/2009 | US20090004229 rupturing controlled release device comprising a subcoat |
| 01/01/2009 | US20090004228 Boron neutron capture therapy; carboranes; cancer |
| 01/01/2009 | US20090004200 Combination treatment of pancreatic cancer |
| 01/01/2009 | US20090004169 Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof |
| 01/01/2009 | US20090004121 Combination of picotamide with nafronyl |